Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

Cited by (826)

Items 501–600 of 826

1. Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk
   Flavien Berthou, Cyril Sobolewski, Daniel Abegg, Margot Fournier, Christine Maeder, Dobrochna Dolicka, Marta Correia de Sousa, Alexander Adibekian, Michelangelo Foti · 2022 · International Journal of Molecular Sciences
2. Changes in FGF21 Serum Concentrations and Liver mRNA Expression in an Experimental Model of Complete Lipodystrophy and Insulin-Resistant Diabetes
   Andrea Špolcová, Martina Holubová, Barbora Mikulášková, V. Nagelová, Andrea Štofková, Z Lacinová, Jana Jur̀čovičová, Martin Haluzı́k, Lenka Maletı́nská, Blanka Železná · 2014 · Physiological Research
3. Low Plasma Levels of Fibroblast Growth Factor-21 in Patients with Peripheral Artery Disease
   Yoshichika Miyazaki, Emi Saita, Yoshimi Kishimoto, Susumu Ibe, Toshiki Seki, Kotaro Miura, Norie Sugihara, Yukinori Ikegami, Reiko Ohmori, Kazuo N. Kondo et al. · 2018 · Journal of Atherosclerosis and Thrombosis
4. Erythropoietin suppresses hepatic steatosis and obesity by inhibiting endoplasmic reticulum stress and upregulating fibroblast growth factor 21
   Ting Hong, Zhijuan Ge, Bingjie Zhang, Ran Meng, Dalong Zhu, Yan Bi · 2019 · International Journal of Molecular Medicine
5. Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects
   Teresa Płatek, Anna Polus, Joanna Góralska, Urszula Raźny, Agnieszka Dziewońska, Agnieszka Micek, Aldona Dembinska-Kiec, Bogdan Solnica, Małgorzata Malczewska-Malec · 2021 · Genes
6. Letter to the Editor: Parameters, Characteristics, and Criteria for Defining the Term “FGF21 Resistance”
   Pongpan Tanajak · 2017 · Endocrinology
7. Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice
   Xinhua Liu, Zachary Graham, Lauren Harlow, Jiangping Pan, Daniella Azulai, William A. Bauman, Joshua F. Yarrow, Christopher P. Cardozo · 2021 · Frontiers in Endocrinology
8. Alteration of BDNF, SPARC, FGF-21, and GDF-15 circulating levels after 1 year of anti-obesity treatments and their association with 1-year weight loss
   Kusuma Chaiyasoot, Nanta Khumkhana, Wanjan Deekum, Chartchai Chaichana, Voraboot Taweerutchana, Nicha Srisuworanan, Pornpoj Pramyothin · 2023 · Endocrine
9. Identification of Sp1 as a Transcription Activator to Regulate Fibroblast Growth Factor 21 Gene Expression
   Shuqin Chen, Huating Li, Jing Zhang, Shan Jiang, Mingliang Zhang, Yilan Xu, Kun Dong, Ying Yang, Qichen Fang, Weiping Jia · 2017 · BioMed Research International
10. Association of fibroblast growth factor 21 with metabolic syndrome and endothelial function in children: a prospective cross-sectional study on novel biomarkers
    Eleni M. Domouzoglou, Antonios P. Vlahos, Vasileios Cholevas, Michail I. Papafaklis, Nikolaos Chaliasos, Ekaterini C. Siomou, Lampros K. Michalis, Agathocles A. Tsatsoulis, Katerina Κ. Naka · 2021 · Annals of Pediatric Endocrinology & Metabolism
11. OXM-104, a potential candidate for the treatment of obesity, NASH and type 2 diabetes
    Simone Anna Melander, Ashref Kayed, Kim Vietz Andreassen, M.A. Karsdal, Kim Henriksen · 2023 · European Journal of Pharmacology
12. Efficacy of a combination of high and low dosage of PEGylated FGF-21 in treatment of diabetes in db/db mice
    Pengfei Xu, Yingjie Zhang, Liying Song, Mir Hassan Khoso, Junyan Li, Xinghao Jiang, Jinjiao He, Jian Li, Xiaohui Ma, Guiping Ren et al. · 2016 · Biomedicine & Pharmacotherapy
13. Prognostic value of plasma fibroblast growth factor 21 among patients with acute ischemic stroke
    Xiaowei Zheng, Zhengbao Zhu, Daoxia Guo, Chongke Zhong, Tan Xu, Yanbo Peng, Aili Wang, Hao Yang Peng, Zhong Ju, Deqin Geng et al. · 2020 · European Journal of Neurology
14. Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase‐4 inhibitor in prediabetic rats
    Pongpan Tanajak, Piangkwan Sa‐nguanmoo, Nattayaporn Apaijai, Xiaojie Wang, Guang Liang, Xiaokun Li, Chao Jiang, Siriporn Chaisin Chattipakorn, Nipon Chattipakorn · 2017 · Cardiovascular Therapeutics
15. Hepato-cardiac interorgan communication controls cardiac hypertrophy via combined endocrine-autocrine FGF21 signaling
    Sobuj Mia, Georgios Siokatas, Rafailia Sidiropoulou, Matthew Hoffman, Konstantinos Fragkiadakis, Eftychia Markopoulou, Mahmoud Elesawy, Rajika Roy, Scott Blair, Yasuhide Kuwabara et al. · 2025 · Cell Reports Medicine
16. Brain-acting hepatokines: its impact on energy balance and metabolism
    Lucía Giovanini, Nahuel Ezequiel Wanionok, Mario Perelló, María Paula Cornejo · 2025 · Frontiers in Neuroscience
17. Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis
    Yong Gang Guo, Ling Li, Shanbiao Hu · 2023 · Renal Failure
18. LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis
    Bing Liu, Yi Zhong, Dandan Huang, Liuye Yang, Pengchao Wang, Yang Liu, Fengxiao Zhang, Xiaoguang Li, Minglu Liang, Kai Huang et al. · 2023 · Metabolism
19. Fibroblast Growth Factor 21 in Gestational Diabetes Mellitus and Type 2 Diabetes Mellitus
    Katarzyna Gawlik, Tomasz Milewicz, Dorota Pawlica-Gosiewska, Iwona Trznadel-Morawska, Bogdan Solnica · 2023 · Journal of Diabetes Research
20. FGF21: A Sharp Weapon in the Process of Exercise to Improve NAFLD
    Zhiyuan Wang, Tingting Sun, Jingjing Yu, Siyu Li, Lijing Gong, Yimin Zhang · 2023 · Frontiers in Bioscience-Landmark
21. Cold exposure modulates potential brown adipokines in humans, but only FGF21 is associated with brown adipose tissue volume
    Andrea Méndez-Gutiérrez, Concepción María Aguilera, Rubén Cereijo, Francisco J. Osuna‐Prieto, Borja Martínez‐Téllez, María Cruz Rico, David Sánchez‐Infantes, Francesc Villarroya, Jonatan R. Ruiz, Guillermo Sánchez‐Delgado · 2024 · Obesity
22. Skeletal muscle mitochondrial uncoupling prevents diabetes but not obesity in NZO mice, a model for polygenic diabesity
    Anja Voigt, Yvonne Katterle, Melanie Kahle, Reinhart Kluge, Annette Schürmann, Hans‐Georg Joost, Susanne Klaus · 2015 · Genes & Nutrition
23. Beyond obesity – thermogenic adipocytes and cardiometabolic health
    Peter Aldiss, Neele S. Dellschaft, Harold S. Sacks, Helen Budge, Michael Edward Symonds · 2017 · Hormone Molecular Biology and Clinical Investigation
24. Balanced Coagonist of GLP-1 and Glucagon Receptors Corrects Dyslipidemia by Improving FGF21 Sensitivity in Hamster Model
    VISHAL G. PATEL, Amit Arvind Joharapurkar, Samadhan Govind Kshirsagar, Hiren Patel, Dheerendra Pandey, Dipam N. Patel, Brijesh Sutariya, Maulik S. Patel, Rajesh H. Bahekar, Mukul Rameshchandra Jain · 2017 · Drug Research
25. Sex modulates the association of fibroblast growth factor 21 with end‐stage renal disease in Asian people with Type 2 diabetes: a 6.3‐year prospective cohort study
    Jianjun Liu, Si Liu, Robin Wai Munn Choo, Shiou Liang Wee, A Xu, Su Chi Lim · 2018 · Diabetic Medicine
26. Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice
    Youxi Yu, Xiaoju Shi, Qianqian Zheng, Xingtong Wang, Xingkai Liu, Min Tan, Guoyue Lv, Ping Zhang, Robert C.G. Martin, Yan Li · 2021 · International Journal of Biological Sciences
27. Heart failure in obesity: insights from proteomics in patients treated with or without weight-loss surgery
    Kristjan Karason, Nicolas Girerd, Johanna C. Andersson‐Assarsson, Kévin Duarte, Magdalena Taube, Per‐Arne Svensson, Anne-Cécile Huby, Markku Peltonen, Lena M. S. Carlsson, Faiez M. Zannad · 2022 · International Journal of Obesity
28. Close association between lifestyle and circulating FGF21 levels: A systematic review and meta-analysis
    Zonghao Qian, Yucong Zhang, Ni Yang, Hao Nie, Zhen Lu Yang, Pengcheng Luo, Xiuxian Wei, Yuqi Guan, Yi Huang, Jinhua Yan et al. · 2022 · Frontiers in Endocrinology
29. Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients
    Ronald Jan Corbee, Dion L. van Everdingen, H.S. Kooistra, Louis C. Penning · 2023 · Frontiers in Veterinary Science
30. Fructose Metabolism and Its Effect on Glucose-Galactose Malabsorption Patients: A Literature Review
    Nawaf W. Alruwaili, Fahad Alshdayed · 2023 · Diagnostics
31. Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice
    Panos G. Ziros, Zoi Zagoriti, George Lagoumintzis, Venetsana E. Kyriazopoulou, Ralitsa P. Iskrenova, Evagelia E Habeos, Gerasimos P. Sykiotis, Dionysios V. Chartoumpekis, Ioannis G. Habeos · 2016 · PLoS ONE
32. Sex Dimorphism in the Fgf21 Gene Expression in Liver and Adipose Tissues is Dependent on the Metabolic Condition
    Н. М. Бажан, Tatiana Jakovleva, Natalia Balybina, Anastasia Dubinina, E. I. Denisova, Natalia A. Feofanova, Makarova En · 2019 · OnLine Journal of Biological Sciences
33. Myokine Responses to Exercise in a Rat Model of Low/High Adaptive Potential
    Wesam F. Farrash, Bethan Eileen Phillips, Steven L. Britton, Nathan Qi, Lauren G. Koch, Daniel James Wilkinson, Kenneth Smith, Philip James Atherton · 2021 · Frontiers in Endocrinology
34. 3-Month post-operative increase in FGF21 is predictive of one-year weight loss after bariatric surgery
    De Luca, Arnaud, Delaye, Jean-Baptiste, Fauchier, Grégoire, Bourbao-Tournois, Céline, Champion, Hélène, Bourdon, Guillaume, Dupont, Joëlle, Froment, Pascal, Dufour, Diane, Ducluzeau, Pierre-Henri · 2023 · Obesity Surgery
35. Moderate-intensity constant or high-intensity interval training? Metabolic effects on candidates to undergo bariatric surgery
    Javier Enríquez-Schmidt, Camila Mautner-Molina, Mariana Kalazich-Rosales, Maximiliano Muñoz, Matías Ruíz-Uribe, Francisca Fuentes-Leal, Manuel A. Monrroy Uarac, Carlos Cárcamo-Ibaceta, Daniel J. Fazakerley, Mark Larance et al. · 2024 · Nutrition Metabolism and Cardiovascular Diseases
36. Mammary adipocytes promote breast tumor cell invasion and angiogenesis in the context of menopause and obesity
    Roopali Roy, Emily Man, Rama Aldakhlallah, Katherine D. Gonzalez, Lauren Merritt, Cassandra C. Daisy, Michael N. Lombardo, Victoria Yordanova, Liang Sun, Biju Isaac et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
37. Distinct genetic signals at the FGF21 locus complicate studies of FGF21's role in diet regulation using human cohort data
    Stina Ramne, Mario García‐Ureña, Matthew Paul Gillum, Lars Henrik Ängquist, Torben Hansen, Jordi Merino, Niels Grarup · 2024 · Molecular Metabolism
38. Longitudinal analysis of genetic and environmental interplay in human metabolic profiles and the implication for metabolic health
    Jing Wang, Alberto Zenere, Xingyue Wang, Göran M.L. Bergström, Fredrik Edfors, Mathias Uhlén, Wen Zhong · 2025 · Genome Medicine
39. The Antidiabetic Activity of Wild-Growing and Cultivated Medicinal Plants Used in Romania for Diabetes Mellitus Management: A Phytochemical and Pharmacological Review
    Diana-Maria Trașcă, Dalia Dop, George Alin Stoica, Ștefan Adrian Niculescu, Niculescu Elena Carmen, Renata Maria Văruț, Cristina Elena Singer · 2025 · Pharmaceuticals
40. FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data
    Chrysoula Boutari, Achilleas Triantafyllou, Lavrentis Papalavrentios, Ioannis Goulis, Emmanouil Sinakos · 2025 · Current Pharmaceutical Design
41. p38α MAPK Regulation of Energy Metabolism in Skeletal Muscle Offers a Therapeutic Path for Type 2 Diabetes
    Eyal Bengal, Sharon Aviram · 2025 · Cells
42. Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease
    Vera Karamfilova, Yavor S. Assyov, Iveta Nedeva, Antoaneta Gateva, Irena D. Ivanova, Nikolay Cherkezov, Ludmila Mateva, Zdravko Asenov Kamenov · 2021 · The Turkish Journal of Gastroenterology
43. FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes
    Ricardo J. Samms, Christine Cheng, Marcel J. Fourcaudot, Sami Heikkinen, Ahmed Khattab, John M. Adams, Eugênio Cersósimo, Curtis L. Triplitt, CURTISS L. PUCKETT, Kostas Tsintzas et al. · 2022 · American Journal of Physiology-Endocrinology and Metabolism
44. Associations Among Cardio-Ankle Vascular Index, Carotid Intima-Media Thickness, and Fibroblast Growth Factor-21 Levels in Kidney Transplant Patients
    Thananda Trakarnvanich, Surazee Prommool, Sathit Kurathong, Taweechai Teepprasan, Y. Wang · 2017 · Transplantation Proceedings
45. p107 Deficiency Increases Energy Expenditure by Inducing Brown‐Fat Thermogenesis and Browning of White Adipose Tissue
    Juan Cuñarro, Xabier Buqué, Sabela Casado, Javier Lugilde, Anxo Vidal, Alfonso Mora, Guadalupe Sabio, Rubén Nogueiras, Patricia Aspichueta, Carlos Diéguez et al. · 2018 · Molecular Nutrition & Food Research
46. Chronic Prednisolone Treatment Aggravates Hyperglycemia in Mice Fed a High-Fat Diet but Does Not Worsen Dietary Fat-Induced Insulin Resistance
    Anke J. Laskewitz, Theo H. van Dijk, Aldo Grefhorst, Marie-José van Lierop, Marijke Schreurs, Vincent W. Bloks, Dirk‐Jan Reijngoud, Wim H.A. Dokter, Folkert Kuipers, Albert Kornelis Groen · 2012 · Endocrinology
47. An Overview of Betaine Supplementation, Sports Performance, and Body Composition
    Jason M. Cholewa, Daniel E. Newmire, Fabrí­cio Eduardo Rossi, Lucas Guimarães‐Ferreira, Nelo Eidy Zanchi · 2018 · Elsevier eBooks
48. Mitiglinide treatment may decreases plasma fibroblast growth factor-21 levels in individuals with new-onset T2DM
    Bo Wang, Gangyi Yang, Mengliu Yang, Yong Liao, Zhiyong Li, Guenther H. Boden, Ling Li · 2011 · Cytokine
49. Fibroblast growth factor 21 resistance is associated with body shape in patients with type 2 diabetes complicating hypertension
    Jing Gan, Zikun Duan, Lu Tang, Zhen Liu, Huiying Tian, Maolan Wu, Yanxue Bi, Xingchao Pan, Wenjun Wang, Xiaotang Gao et al. · 2023 · Frontiers in Cardiovascular Medicine
50. Maternal overweight and obesity modify the association of serum fibroblast growth factor 21 levels with gestational diabetes mellitus: A nested case‐control study
    Ping Wu, Linjing Wu, Yi Wang, Yi Ye, Xue Yang, Jiaying Yuan, Jianguo Xu, Yixin Wang, Xingyue Song, Shijiao Yan et al. · 2023 · Diabetes/Metabolism Research and Reviews
51. Physical Exercise-Induced FGF-21 to Fight Obesity: An Update Review
    Bruno Vecchiatto, Thiago Lucas de Castro, Cynthia R. Muller, Anna Karenina Azevedo‐Martins, Fabiana S. Evangelista · 2022 · Obesities
52. Heparin is essential for optimal cell signaling by FGF21 and for regulation of βKlotho cellular stability
    Seong J. An, Jyotidarsini Mohanty, Francisco Tomé, Yoshihisa Suzuki, Irit Lax, Joseph Schlessinger · 2023 · Proceedings of the National Academy of Sciences
53. The associations of adipokines with hypertension in youth with cardiometabolic risk and the mediation role of insulin resistance: The BCAMS study
    Bo Li, Cong Hou, Lianxia Li, Ming Li, Shan Gao · 2023 · Hypertension Research
54. Association of the 3′UTR polymorphism (rs11665896) in the FGF21 gene with metabolic status and nutrient intake in children with obesity
    Alan Joel Ruiz-Padilla, Gerardo Morales-Hernandez, Yeniley Ruíz‐Noa, Ángel Josabad Alonso‐Castro, María-Luisa Lazo-de-la-Vega-Monroy, Mónica del Carmen Preciado‐Puga, Rubén Rangel-Salazar, Lorena del Rocío Ibarra‐Reynoso · 2019 · Journal of Pediatric Endocrinology and Metabolism
55. Potential of Hibiscus sabdariffa Linn. in managing FGF21 resistance in diet‐induced‐obesity rats via miR‐34a regulation
    Neng Tine Kartinah, Nisa Kartika Komara, Nuraini Diah Noviati, Syarifah Dewi, Sophie Yolanda, Afifa Radhina, Heriyanto Heriyanto, Imelda Rosalyn Sianipar · 2021 · Veterinary Medicine and Science
56. The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitus
    Zahra Heidari, Mahdieh Hasanpour · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
57. Ingestion of eicosapentaenoic acid in the early stage of social isolation reduces a fibroblast growth factor 21 resistant state independently of body weight in KKAy mice
    Katsunori Nonogaki, Tomoe Yamazaki, Mari Murakami, Takao Kaji · 2015 · Biochemical and Biophysical Research Communications
58. Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation
    Laurie R. Braun, Meghan N. Feldpausch, Natalia Czerwonka, Martin Torriani, Steven Kyle Grinspoon, Takara Leah Stanley · 2017 · Growth Hormone & IGF Research
59. FGF21-protection against fructose-induced lipid accretion and oxidative stress is influenced by maternal nutrition in male progeny
    Elena Fauste, Silvia Rodrigo, Lourdes Rodríguez, Cristina Donis, Antonia Garcı́a, Coral Barbas, Juan J. Álvarez‐Millán, Maria Isabel Panadero, Paola Otero, Carlos Bocos · 2019 · Journal of Functional Foods
60. Circulating Diabetic Candidate Neurotrophic Factors, Brain-Derived Neurotrophic Factor and Fibroblast Growth Factor 21, in Sleeve Gastrectomy
    Hung‐Hsuan Yen, Sung‐Tsang Hsieh, Chi‐Ling Chen, Wei‐Shiung Yang, Po‐Chu Lee, Ming‐Tsan Lin, Chiung‐Nien Chen, Po‐Jen Yang · 2020 · Scientific Reports
61. Fibroblast growth factor 21 and dietary interventions: what we know and what we need to know next
    Tianru Jin · 2022 · Medical Review
62. Hepatokine‐based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients
    Martin Franck, Katharina John, Sherin Al Aoua, Monika Rau, Andreas Geier, Jörn Markus Schattenberg, Heiner H. Wedemeyer, Klaus Schulze‐Osthoff, Heike Bantel · 2023 · Liver International
63. Relationship of postprandial fibroblast growth factor 21 with lipids, inflammation and metabolic dysfunction-associated fatty liver disease during oral fat tolerance test
    Xiaolong Li, Kunjie Zheng, Lifang Liu, Tingfu Zhang, Wei Gu, Xiaoyu Hou, Jianlin Geng, Guangyao Song · 2024 · Frontiers in Endocrinology
64. ADAM10-mediated β-klotho degradation: a key to FGF21 resistance in senescent vascular endothelial cells
    Yuzhen Huang, Yucong Zhang, Ni Yang, Zonghao Qian, Ziwei Fang, Lang Zeng, Yi Huang, Han Li, Mandi Luo, Jinhua Yan et al. · 2024 · GeroScience
65. Exploring the Associations Between Inflammatory Biomarkers, Survival, and Cardiovascular Events in Hemodialysis Patients and the Interrelationship with Nutritional Parameters—The Experience of a Single Transylvanian Dialysis Center
    Crina Claudia Rusu, Ina Maria Kacsó, Diana Tania Moldovan, Alina Ramona Potra, Dacian Călin Tirinescu, Maria Ţicală, Yuriy Maslyennikov, Alexandra Urs, Cosmina Ioana Bondor · 2025 · Journal of Clinical Medicine
66. The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis
    Arsenios Magdas, Jingzhong Ding, Robyn L. McClelland, Matthew Allison, Philip J. Barter, Kerry‐Anne Rye, Kwok Leung Ong · 2019 · Scientific Reports
67. Fibroblast Growth Factor 21 Is Elevated in HIV and Associated With Interleukin-6
    Allison Ross Eckard, Heather Hughes, Nancy L. Hagood, Mary Ann O’Riordan, Danielle E. Labbato, Julia C. Kosco, Sarah Scott, Grace A. McComsey · 2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes
68. Optimization of Peptide Inhibitors of β-Klotho as Antagonists of Fibroblast Growth Factors 19 and 21
    Jia Bao Pan, Sebastian Demian Parlee, Florence M. Brunel, Pengyun Li, Wei Lu, Diego Pérez–Tilve, Fa Liu, Brian Finan, Alexei Kharitonenkov, Richard D. DiMarchi · 2020 · ACS Pharmacology & Translational Science
69. Insight to the association among fibroblast growth factor 21, non-alcoholic fatty liver disease and cardiovascular outcomes: A population-based study
    Yun Shen, Tingting Hu, Hongyu Tan, Yiting Xu, Yufei Wang, Xiaojing Ma, Yuqian Bao · 2023 · Cytokine
70. Relationship between family history of type 2 diabetes and serum FGF 21
    Greggory R. Davis, Tiffany Deville, Joshua Guillory, David Michael Bellar, Arnold G. Nelson · 2017 · European Journal of Clinical Investigation
71. Changes in Liver Gene Expression and Plasma Concentration of Rbp4, Fetuin-A, and Fgf21 in Sprague-Dawley Rats Subjected to Different Dietary Interventions and Bariatric Surgery
    Dominika Marta Stygar, Wojciech Pigłowski, Elżbieta Chełmecka, Bronisława Skrzep-Poloczek, Tomasz Sawczyn, Wojciech Garłowski, Jerzy Jochem, Konrad Wojciech Karcz · 2018 · BioMed Research International
72. Impact of sex on the adaptation of adult mice to long consumption of sweet-fat diet
    Н. М. Бажан, Tatiana Iakovleva, Anastasia Dubinina, Makarova En · 2020 · Vavilov Journal of Genetics and Breeding
73. The Hepatokine FGF21 Increases the Human Spermatozoa Motility
    Guillaume Bourdon, A. Estienne, C. Chevaleyre, C. Ramé, F. Guérif, J. Brun, C. Vasseur, G. Fromont, I. Plotton, Diane Dufour-Rainfray et al. · 2022 · Frontiers in Endocrinology
74. The effect of different weight loss strategies to treat non-alcoholic fatty liver disease focusing on fibroblast growth factor 21
    Nicole Power Guerra, Katharina Leyens, Luisa Müller, David Brauer, Deborah Janowitz, Samin Schlick, Kristin Pilz, Hans Jörgen Grabe, Brigitte Vollmar, Angela Kuhla · 2022 · Frontiers in Nutrition
75. Do Sugar-Sweetened Beverages Increase Fasting FGF21 Irrespective of the Type of Added Sugar? A Secondary Exploratory Analysis of a Randomized Controlled Trial
    Bettina Geidl, Michel Hochuli, Giatgen A. Spinas, Philipp A. Gerber · 2022 · Nutrients
76. Resistance to the Beneficial Metabolic Effects and Hepatic Antioxidant Defense Actions of Fibroblast Growth Factor 21 Treatment in Growth Hormone-Overexpressing Transgenic Mice
    Ravneet Kaur Boparai, Oge Arum, Johanna Gabriela Miquet, Michał M. Masternak, Andrzej Bartke, Romesh K. Khardori · 2015 · International Journal of Endocrinology
77. A combined docosahexaenoic acid–thyroid hormone protocol upregulates rat liver β-Klotho expression and downstream components of FGF21 signaling as a potential novel approach to metabolic stress conditions
    Romina Vargas, Bárbara Riquelme, Javier Fernández, Luis Alberto Videla · 2017 · Food & Function
78. Effects of beta-conglycinin intake on circulating FGF21 levels and brown adipose tissue activity in Japanese young men: a single intake study and a randomized controlled trial
    Hirokazu Taniguchi, Keigo Shimizu, Sayori Wada, Shinsuke Nirengi, Haruki Kataoka, Akane Higashi · 2020 · Journal of PHYSIOLOGICAL ANTHROPOLOGY
79. Lack of Day/Night variation in fibroblast growth factor 21 levels in young healthy men
    Joo‐Pin Foo, Konstantinos N. Aronis, John P. Chamberland, Christos Socrates Mantzoros · 2014 · International Journal of Obesity
80. Adiposity Is a Key Correlate of Circulating Fibroblast Growth Factor-21 Levels in African Males with or without Type 2 Diabetes Mellitus
    Fredirick L. Mashili, Kaushik L. Ramaiya, Janet K. Lutale, Marina Alois Njelekela, Filbert T. Francis, Juleen Rae Zierath, Anna Krook · 2018 · Journal of Obesity
81. A Chronic GM(2) Gangliosidosis Variant with a HEXA Splicing Defect: Quantitation of HEXA mRNAs in Normal and Mutant Fibroblasts
    Mauro Juarez Fernandes, Peter Hechtman, Bernard Boulay, Feige Kaplan · 1997 · European Journal of Human Genetics
82. RIFL aims to be a new player in lipid metabolism
    Jacqueline M. Stephens · 2012 · American Journal of Physiology-Endocrinology and Metabolism
83. Commentary: FGF21 Holds Promises for Treating Obesity-related Insulin Resistance and Hepatosteatosis
    Anna Alisi, Nadia Panera, Valério Nobili · 2013 · Endocrinology
84. Skeletal muscle growth to combat diabetes and obesity: the potential role of muscle‐secreted factors
    Mitchell J. Sammut, Benjamin R. Thorne, C.W. James Melling · 2025 · Obesity
85. Pharmacological but Not Physiological Levels of GDF15 and FGF21 Regulate Body Weight and Glycemic Control in Obese Mice
    Sarah Engelbeen, Julie Mie Jacobsen, Luisa Deisen, Elisa Parsche, Alberte Silke Buch-Rasmussen, Christoffer Clemmensen, Rune E. Kuhre, Kornelia Johann, Maximilian Kleinert · 2025 · The FASEB Journal
86. Effects of low fat diet on inflammatory parameters in individuals with obesity/overweight and non-alcoholic fatty liver disease: A cross-sectional study
    Nur Bengü Erdem, Evrim Kahramanoğlu Aksoy, Derya Dikmen, Kübra Uçar, A. Ağaçdiken, Merve İlhan Esgin, Zeynep Göktaş · 2024 · Medicine
87. Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice
    Jia Nuo Feng, Weijuan Shao, Lin Yang, Juan Pang, Wenhua Ling, Dinghui Liu, Michael B. Wheeler, Housheng Hansen He, Tianru Jin · 2025 · Nutrition and Diabetes
88. Adipocinas: uma visão geral dos seus efeitos metabólicos
    Amélio F. Godoy‐Matos, Ivan Cruz, Rafael da Silva Costa, Wellington Santana da Silva Júnior, Brazilian Adipokines Study Group · 2014 · Revista Hospital Universitário Pedro Ernesto
89. Pharmacokinetics, tissue distribution, and excretion of FGF‐21 following subcutaneous administration in rats
    Yufei He, Yazhuo Li, Zihong Wei, Xingyan Zhang, Jing Gao, Xiaojie Wang, Xiaokun Li, Weidang Wu, Wěi Li, Xiulin Yi et al. · 2018 · Drug Testing and Analysis
90. Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus
    Hirokazu Taniguchi, Shinsuke Nirengi, Kengo Ishihara, Naoki Sakane · 2022 · PLoS ONE
91. Promotion of diet‐induced obesity and metabolic syndromes by BID is associated with gut microbiota
    Shengmin Yan, Jun Zhou, Hao Zhang, Zhen Nan Lin, Bilon Khambu, Gang Liu, Michelle Ma, Xiaoyun Chen, Naga Chalasani, Xiao‐Ming Yin · 2022 · Hepatology Communications
92. Circulating AFABP, FGF21, and PEDF Levels as Prognostic Biomarkers of Sight-threatening Diabetic Retinopathy
    Chi‐Ho Lee, David Tak Wai Lui, Chloe Y. Y. Cheung, Carol Ho-Yan Fong, Michele Mae Ann Yuen, Yu Cho Woo, Wing-Sun Chow, Ian Yat-Hin Wong, Aimin Xu, Karen S.L. Lam · 2023 · The Journal of Clinical Endocrinology & Metabolism
93. α1-Adrenergic receptor downregulates hepatic FGF21 production and circulating FGF21 levels in mice
    Katsunori Nonogaki, Takao Kaji · 2016 · Neuroscience Letters
94. Rapamycin‐ameliorated diabetic symptoms involved in increasing adiponectin expression in diabetic mice on a high‐fat diet
    Fanghua Gong, Yanna Ye, Jinmeng Li, Haiyang Zhao, Xiaokun Li · 2017 · The Kaohsiung Journal of Medical Sciences
95. Fibroblast Growth Factor 21 as a Potential Biomarker for Improved Locomotion and Olfaction Detection Ability after Weight Reduction in Obese Mice
    Nicole Power Guerra, Alisha Parveen, Daniel Bühler, David Brauer, Luisa Müller, Kristin Pilz, Martin Witt, Anne S. Glass, Rika Bajorat, Deborah Janowitz et al. · 2021 · Nutrients
96. Novel Adipokines CTRP1, CTRP9, and FGF21 in Pediatric Type 1 and Type 2 Diabetes: A Cross-Sectional Analysis
    Alexander Arking, Dylan C. Sarver, Sheela Natesh Magge, Guang William Wong, Risa M. Wolf · 2022 · Hormone Research in Paediatrics
97. Adipose Tissue as an Endocrine Organ
    Hannah Hui, Tianshi Feng · 2018 · InTech eBooks
98. Parkin depletion prevents the age-related alterations in the FGF21 system and the decline in white adipose tissue thermogenic function in mice
    Alejandro Delgado‐Anglés, Albert Blasco‐Roset, Francisco J. Godoy-Nieto, Montserrat Cairó, Francesc Villarroya, Marta Giralt, Joan Villarroya · 2023 · Journal of Physiology and Biochemistry
99. Transitions in chromatin conformation shaped by fatty acids and the circadian clock underlie hepatic transcriptional reorganization in obese mice
    Ignacio Pacheco-Bernal, Fernando Becerril-Pérez, Marcia Bustamante-Zepeda, Mirna González-Suárez, Miguel Ángel Olmedo-Suárez, Luis Ricardo Hernández-Barrientos, Alejandro Alarcón del Carmen, Quetzalcóatl Escalante‐Covarrubias, Lucía Mendoza-Viveros, Enrique Hernandez Lemus et al. · 2024 · Cellular and Molecular Life Sciences
100. The association between circulating irisin, osteocalcin and FGF21 levels with anthropometric characteristics and blood lipid profile in young obese male subjects
     Sema Etiz Sayharman, Muaz Belviranlı, Nilsel Okudan · 2025 · Advances in Medical Sciences